1. Home
  2. CABA vs HAIN Comparison

CABA vs HAIN Comparison

Compare CABA & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CABA
  • HAIN
  • Stock Information
  • Founded
  • CABA 2017
  • HAIN 1993
  • Country
  • CABA United States
  • HAIN United States
  • Employees
  • CABA N/A
  • HAIN 2786
  • Industry
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • HAIN Packaged Foods
  • Sector
  • CABA Health Care
  • HAIN Consumer Staples
  • Exchange
  • CABA Nasdaq
  • HAIN Nasdaq
  • Market Cap
  • CABA 149.3M
  • HAIN 159.7M
  • IPO Year
  • CABA 2019
  • HAIN 1993
  • Fundamental
  • Price
  • CABA $1.71
  • HAIN $1.89
  • Analyst Decision
  • CABA Strong Buy
  • HAIN Hold
  • Analyst Count
  • CABA 7
  • HAIN 9
  • Target Price
  • CABA $14.29
  • HAIN $3.85
  • AVG Volume (30 Days)
  • CABA 1.3M
  • HAIN 1.2M
  • Earning Date
  • CABA 08-07-2025
  • HAIN 09-15-2025
  • Dividend Yield
  • CABA N/A
  • HAIN N/A
  • EPS Growth
  • CABA N/A
  • HAIN N/A
  • EPS
  • CABA N/A
  • HAIN N/A
  • Revenue
  • CABA N/A
  • HAIN $1,615,231,000.00
  • Revenue This Year
  • CABA N/A
  • HAIN N/A
  • Revenue Next Year
  • CABA N/A
  • HAIN N/A
  • P/E Ratio
  • CABA N/A
  • HAIN N/A
  • Revenue Growth
  • CABA N/A
  • HAIN N/A
  • 52 Week Low
  • CABA $0.99
  • HAIN $1.30
  • 52 Week High
  • CABA $6.26
  • HAIN $9.43
  • Technical
  • Relative Strength Index (RSI)
  • CABA 57.70
  • HAIN 61.96
  • Support Level
  • CABA $1.26
  • HAIN $1.58
  • Resistance Level
  • CABA $1.56
  • HAIN $1.70
  • Average True Range (ATR)
  • CABA 0.12
  • HAIN 0.10
  • MACD
  • CABA 0.00
  • HAIN 0.02
  • Stochastic Oscillator
  • CABA 92.78
  • HAIN 87.21

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

Share on Social Networks: